The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Electroconvulsive Therapy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Electroconvulsive Therapy


Psychiatry related information on Electroconvulsive Therapy


High impact information on Electroconvulsive Therapy


Chemical compound and disease context of Electroconvulsive Therapy


Biological context of Electroconvulsive Therapy


Anatomical context of Electroconvulsive Therapy


Gene context of Electroconvulsive Therapy


Analytical, diagnostic and therapeutic context of Electroconvulsive Therapy


  1. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Holcomb, H.H., Sternberg, D.E., Heninger, G.R. Biol. Psychiatry (1983) [Pubmed]
  2. The effect of seizures on hormones. Pritchard, P.B. Epilepsia (1991) [Pubmed]
  3. Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine. Stead, M., Josephs, K.A. Headache. (2005) [Pubmed]
  4. Propofol and electroconvulsive therapy in a patient at risk from acute intermittent porphyria. Shaw, I.H., McKeith, I.G. British journal of anaesthesia. (1998) [Pubmed]
  5. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Howie, M.B., Black, H.A., Zvara, D., McSweeney, T.D., Martin, D.J., Coffman, J.A. Anesth. Analg. (1990) [Pubmed]
  6. Finding the intracellular signaling pathways affected by mood disorder treatments. Coyle, J.T., Duman, R.S. Neuron (2003) [Pubmed]
  7. Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. Devanand, D.P., Sackeim, H.A., Lo, E.S., Cooper, T., Huttinot, G., Prudic, J., Ross, F. Arch. Gen. Psychiatry (1991) [Pubmed]
  8. Influence of L-triiodothyronine on memory following repeated electroconvulsive shock in rats: implications for human electroconvulsive therapy. Stern, R.A., Whealin, J.M., Mason, G.A., Noonan, L.R., Silva, S.G., Arruda, J.E., Prange, A.J. Biol. Psychiatry (1995) [Pubmed]
  9. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia. Horne, R.L., Pettinati, H.M., Menken, M., Sugerman, A.A., Varga, E., Wilson, G.F. Biol. Psychiatry (1984) [Pubmed]
  10. Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study. Shiah, I.S., Yatham, L.N., Srisurapanont, M., Lam, R.W., Tam, E.M., Zis, A.P. Journal of clinical psychopharmacology. (2000) [Pubmed]
  11. Propofol and electroconvulsive therapy. Rampton, A.J., Griffin, R.M., Durcan, J.J., Stuart, C.S. Lancet (1988) [Pubmed]
  12. Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy. Scott, A.I., Whalley, L.J., Bennie, J., Bowler, G. Lancet (1986) [Pubmed]
  13. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. Costain, D.W., Cowen, P.J., Gelder, M.G., Grahame-Smith, D.G. Lancet (1982) [Pubmed]
  14. The Northwick Park electroconvulsive therapy trial. Johnstone, E.C., Deakin, J.F., Lawler, P., Frith, C.D., Stevens, M., McPherson, K., Crow, T.J. Lancet (1980) [Pubmed]
  15. Complicated mania. Comorbidity and immediate outcome in the treatment of mania. Black, D.W., Winokur, G., Bell, S., Nasrallah, A., Hulbert, J. Arch. Gen. Psychiatry (1988) [Pubmed]
  16. The 24-hour profile of plasma prolactin in men with major endogenous depressive illness. Linkowski, P., Van Cauter, E., L'Hermite-Baleriaux, M., Kerkhofs, M., Hubain, P., L'Hermite, M., Mendlewicz, J. Arch. Gen. Psychiatry (1989) [Pubmed]
  17. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Nobler, M.S., Sackeim, H.A., Prohovnik, I., Moeller, J.R., Mukherjee, S., Schnur, D.B., Prudic, J., Devanand, D.P. Arch. Gen. Psychiatry (1994) [Pubmed]
  18. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Davidson, J., McLeod, M., Law-Yone, B., Linnoila, M. Arch. Gen. Psychiatry (1978) [Pubmed]
  19. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Ende, G., Braus, D.F., Walter, S., Weber-Fahr, W., Henn, F.A. Arch. Gen. Psychiatry (2000) [Pubmed]
  20. Succinylcholine drug interactions during electroconvulsive therapy. Marco, L.A., Randels, P.M. Biol. Psychiatry (1979) [Pubmed]
  21. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Fu, W., Stool, L.A., White, P.F., Husain, M.M. Anesth. Analg. (1998) [Pubmed]
  22. Circulatory responses during electroconvulsive therapy. The comparative effects of placebo, esmolol and nitroglycerin. O'Flaherty, D., Husain, M.M., Moore, M., Wolff, T.R., Sills, S., Giesecke, A.H. Anaesthesia. (1992) [Pubmed]
  23. Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Anderson, D.N., Wilkinson, A.M., Abou-Saleh, M.T., Blair, J.A. Acta psychiatrica Scandinavica. (1994) [Pubmed]
  24. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Gold, P.W., Wong, M.L., Goldstein, D.S., Gold, H.K., Ronsaville, D.S., Esler, M., Alesci, S., Masood, A., Licinio, J., Geracioti, T.D., Perini, G., DeBellis, M.D., Holmes, C., Vgontzas, A.N., Charney, D.S., Chrousos, G.P., McCann, S.M., Kling, M.A. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  25. Effect of electroconvulsive therapy on erythrocyte adenosine triphosphatase activity in depressive illness. Whalley, L.J., Scott, M., Reading, H.W., Christie, J.E. The British journal of psychiatry : the journal of mental science. (1980) [Pubmed]
  26. The comparative effects of propofol versus thiopental on middle cerebral artery blood flow velocity during electroconvulsive therapy. Saito, S., Kadoi, Y., Nara, T., Sudo, M., Obata, H., Morita, T., Goto, F. Anesth. Analg. (2000) [Pubmed]
  27. Platelet alpha 2 adrenoreceptors are decreased in number after antidepressant therapy. Smith, C.B., Hollingsworth, P.J., Garcia-Sevilla, J.A., Zis, A.P. Prog. Neuropsychopharmacol. Biol. Psychiatry (1983) [Pubmed]
  28. Management for electroconvulsive therapy of a patient with inoperable coronary artery disease and ankylosing spondylitis. Snyder, D.S., Lipsey, J.R., McPherson, R.W. Journal of clinical anesthesia. (1992) [Pubmed]
  29. Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations. Kronfol, Z., Hamdan-Allen, G., Goel, K., Hill, E.M. Psychoneuroendocrinology (1991) [Pubmed]
  30. Melatonin in humans physiological and clinical studies. Wetterberg, L. J. Neural Transm. Suppl. (1978) [Pubmed]
  31. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Apéria, B., Bergman, H., Engelbrektson, K., Thorén, M., Wetterberg, L. Acta psychiatrica Scandinavica. (1985) [Pubmed]
  32. Attenuation of HPA axis hyperactivity and simultaneous clinical deterioration in a depressed patient treated with mirtazapine. Schüle, C., Baghai, T., Zwanzger, P., Rupprecht, R. World J. Biol. Psychiatry (2001) [Pubmed]
  33. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Sackeim, H.A., Luber, B., Katzman, G.P., Moeller, J.R., Prudic, J., Devanand, D.P., Nobler, M.S. Arch. Gen. Psychiatry (1996) [Pubmed]
  34. GABAergic dysfunction in mood disorders. Brambilla, P., Perez, J., Barale, F., Schettini, G., Soares, J.C. Mol. Psychiatry (2003) [Pubmed]
  35. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Grunhaus, L., Dannon, P.N., Schreiber, S., Dolberg, O.H., Amiaz, R., Ziv, R., Lefkifker, E. Biol. Psychiatry (2000) [Pubmed]
  36. Acute rise of pancreatic polypeptide after electroconvulsive therapy. Allen, J.M., Adrian, T.E., Cramer, P., Steinert, J., Bloom, S.R. The British journal of psychiatry : the journal of mental science. (1982) [Pubmed]
  37. Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. Perisse, D., Amoura, Z., Cohen, D., Saintigny, P., Mekhloufi, F., Mazet, P., Piette, J.C. Journal of the American Academy of Child and Adolescent Psychiatry. (2003) [Pubmed]
  38. Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen. Bergsholm, P., Gran, L., Bleie, H. Acta psychiatrica Scandinavica. (1984) [Pubmed]
WikiGenes - Universities